Ketanest

Esketamine Hydrochloride, the active ingredient in Ketanest, is a NMDA receptor antagonist presented as an injection solution for intramuscular and intravenous use. It provides dissociative anesthesia and analgesia for patients undergoing surgical or procedural sedation.

GNH USA supplies Ketanest as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketanest, an NMDA receptor antagonist, is employed in clinical settings that require rapid, controllable anesthesia and analgesia.

Induction of anesthesia: Provides quick onset of dissociative anesthesia for surgical procedures. Procedural sedation: Enables safe sedation for diagnostic or minor therapeutic interventions. Analgesia: Delivers effective pain relief during and after procedures.

Ketanest may cause a range of adverse reactions, which vary in frequency and severity.

Common Side Effects: - Dizziness: Transient sensation of light‑headedness during or after administration. - Nausea or vomiting: Gastrointestinal upset commonly reported post‑dose. - Hypertension: Temporary rise in blood pressure. - Headache: Mild to moderate headache occurring during recovery.

Serious or Rare Side Effects: - Respiratory depression: Reduced breathing effort requiring monitoring. - Emergence reactions: Agitation, vivid dreams, or hallucinations during awakening. - Severe hypertension or hypertensive crisis: Marked increase in blood pressure needing immediate intervention. - Allergic reactions: Rash, itching, or anaphylaxis in susceptible individuals.

Prior to using Ketanest, clinicians should consider several safety measures.

Cardiovascular monitoring: Observe blood pressure and heart rate due to possible hypertension. Respiratory support: Ensure airway management equipment is available for potential respiratory depression. Psychiatric assessment: Evaluate for history of psychosis or severe mental illness before administration. Drug interactions: Review concomitant CNS depressants or sympathomimetic agents. Store at ambient temperature: Keep in original container, protect from light and moisture.

Ketanest can interact with other medications, requiring careful management.

Major Interactions (Avoid): - Monoamine oxidase inhibitors: May precipitate hypertensive crisis. - Other NMDA antagonists: Can produce additive CNS depression. - Central nervous system depressants (e.g., benzodiazepines, opioids): Heightened sedation and respiratory risk.

Moderate Interactions (Monitor Closely): - Sympathomimetic agents: May amplify blood pressure elevations. - Inhalational anesthetics: May necessitate dose adjustments of Ketanest. - Antihypertensive drugs: Could blunt the expected rise in blood pressure during induction.